Search research articles
Contact Us
Filters
Showing results (121-130 of 155) with videos related to
Page
of 16
Sort By:
Frontiers in Neurology
|
April 18, 2022
Corrigendum: Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy
Quang Tuan Rémy Nguyen, Juan Dario Ortigoza Escobar, Jean-Marc Burgunder, et al.
Frontiers in Neurology
|
February 28, 2022
Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy
Quang Tuan Rémy Nguyen, Juan Dario Ortigoza Escobar, Jean-Marc Burgunder, et al.
Neurology
|
March 26, 2021
Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease
Branduff McAllister, James F Gusella, G Bernhard Landwehrmeyer, et al.
Plos One
|
November 9, 2019
Olfactory screening of Parkinson's Disease patients and healthy subjects in China and Germany: A study of cross-cultural adaptation of the Sniffin' Sticks 12-identification test
Elmar H Pinkhardt, Huijing Liu, Di Ma, et al.
Clinical Chemistry
|
October 13, 2025
Age-Specific Control and Alzheimer Disease Reference Curves and z-Scores for Glial Fibrillary Acidic Protein in Blood
Steffen Halbgebauer, Badrieh Fazeli, Veronika Klose, et al.
Parkinsonism & Related Disorders
|
February 23, 2016
Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease
Saul Martinez-Horta, Jesus Perez-Perez, Erik van Duijn, et al.
Neuroimage. Clinical
|
November 2, 2013
Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approach
Hans-Peter Müller, Georg Grön, Reiner Sprengelmeyer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 16, 2014
Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)
Erik van Duijn, David Craufurd, Anna A M Hubers, et al.
The Lancet. Neurology
|
December 20, 2018
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
Ralf Reilmann, Andrew McGarry, Igor D Grachev, et al.
Plos Currents
|
January 29, 2016
Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical Performance
Ruth Keogh, Chris Frost, Gail Owen, et al.
Page
of 16
Search research articles
Search
Showing results (121-130 of 155) with videos related to
Sort By:
Page
of 16
Frontiers in Neurology
|
April 18, 2022
Corrigendum: Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy
Quang Tuan Rémy Nguyen, Juan Dario Ortigoza Escobar, Jean-Marc Burgunder, et al.
Frontiers in Neurology
|
February 28, 2022
Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy
Quang Tuan Rémy Nguyen, Juan Dario Ortigoza Escobar, Jean-Marc Burgunder, et al.
Neurology
|
March 26, 2021
Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease
Branduff McAllister, James F Gusella, G Bernhard Landwehrmeyer, et al.
Plos One
|
November 9, 2019
Olfactory screening of Parkinson's Disease patients and healthy subjects in China and Germany: A study of cross-cultural adaptation of the Sniffin' Sticks 12-identification test
Elmar H Pinkhardt, Huijing Liu, Di Ma, et al.
Clinical Chemistry
|
October 13, 2025
Age-Specific Control and Alzheimer Disease Reference Curves and z-Scores for Glial Fibrillary Acidic Protein in Blood
Steffen Halbgebauer, Badrieh Fazeli, Veronika Klose, et al.
Parkinsonism & Related Disorders
|
February 23, 2016
Neuropsychiatric symptoms are very common in premanifest and early stage Huntington's Disease
Saul Martinez-Horta, Jesus Perez-Perez, Erik van Duijn, et al.
Neuroimage. Clinical
|
November 2, 2013
Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approach
Hans-Peter Müller, Georg Grön, Reiner Sprengelmeyer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
May 16, 2014
Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY)
Erik van Duijn, David Craufurd, Anna A M Hubers, et al.
The Lancet. Neurology
|
December 20, 2018
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study
Ralf Reilmann, Andrew McGarry, Igor D Grachev, et al.
Plos Currents
|
January 29, 2016
Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical Performance
Ruth Keogh, Chris Frost, Gail Owen, et al.
Page
of 16